Metrovacesa Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Other Revenue	708.37	653.07	580.62	515.75	512.1
Total Revenue	708.37	653.07	580.62	515.75	512.1
Revenue Growth (YoY	8.47%	12.48%	12.58%	0.71%	266.21%
Property Expenses	528.83	529.72	458.84	422.13	407.32
Selling, General & Administrative	32.16	34.81	33.46	34.23	36.57
Other Operating Expenses	19.84	15.79	19.95	17.02	16.04
Total Operating Expenses	582.05	576.99	515.43	479.98	454.56
Operating Income	126.32	76.08	65.2	35.77	57.54
Interest Expense	-26.91	-37.29	-22.98	-11.22	-15.4
Interest & Investment Income	11.65	14.68	2.24	-	-
Other Non-Operating Income	-1.57	-3.09	-3.99	4.86	0.34
EBT Excluding Unusual Items	109.48	50.37	40.47	29.41	42.47
Gain (Loss) on Sale of Investments	-45.49	-28.56	-61.94	-47.13	-23.44
Asset Writedown	8.55	2.65	4.96	-0.55	4.69
Pretax Income	72.54	24.46	-16.51	-18.28	23.73
Income Tax Expense	15.68	8.58	4.34	5.2	5.27
Earnings From Continuing Operations	56.86	15.89	-20.84	-23.48	18.46
Net Income	56.86	15.89	-20.84	-23.48	18.46
Net Income to Common	56.86	15.89	-20.84	-23.48	18.46
Net Income Growth	257.94%	-	-	-	-
Basic Shares Outstanding	152	152	151	151	151
Diluted Shares Outstanding	152	152	151	151	151
Shares Change (YoY)	0.03%	0.03%	0.04%	-0.01%	0.00%
EPS (Basic)	0.38	0.10	-0.14	-0.16	0.12
EPS (Diluted)	0.38	0.10	-0.14	-0.16	0.12
EPS Growth	257.92%	-	-	-	-
Operating Margin	17.83%	11.65%	11.23%	6.94%	11.24%
Profit Margin	8.03%	2.43%	-3.59%	-4.55%	3.60%
EBITDA	127.54	79.26	68.38	42.37	63.62
EBITDA Margin	18.00%	12.14%	11.78%	8.21%	12.42%
D&A For Ebitda	1.23	3.18	3.18	6.6	6.08
EBIT	126.32	76.08	65.2	35.77	57.54
EBIT Margin	17.83%	11.65%	11.23%	6.94%	11.24%
Effective Tax Rate	21.61%	35.07%	-	-	22.19%